Mutations in the epidermal growth factor receptor (EGFR) are common in non-small cell lung cancer (NSCLC), accounting for approximately 50% of cases in Asians and 25% in Caucasians (Lynch et al., 2004). Here, EGFR is linked to non-small cell lung carcinoma.